Jinga Life to address the challenge of Gestational Diabetes

We are delighted to have been awarded a place on Enterprise Ireland’s Small Business Innovation Research (SBIR) programme, following a competitive call.

The award follows a competitive Challenge arising from the first SBIR collaboration between Enterprise Ireland and the Health Service Executive (HSE), with the joint goal of delivering improved patient care through intelligent use of technology. The Challenge we are involved in aims to specifically target reducing the risk of women developing Type 2 diabetes following gestational diabetes.

Gestational Diabetes Mellitus (GDM) is a global issue which affects 1 in 6 pregnancies globally. The main contributing factors for GDM development are: obesity, with 30% of the pregnant population being obese; rising maternal age and background Type 2 diabetes rates in the population. Of the 130 million global births annually, 21 million are affected by Diabetes of which 17.6 million have GDM. 50% (or 8.8 million) are likely to develop Type 2 Diabetes after 10 years. Through this SBIR support, the HSE are seeking new technology to underpin a comprehensive solution to reduce the proportion of women who progress from gestational diabetes (GDM) to Pre-Diabetes and Type 2 Diabetes .

https://www.enterprise-ireland.com/en/News/PressReleases/2019-Press-Releases/Enterprise-Ireland-and-HSE-award-five-companies-innovation-contracts-to-address-diabetes.html